Tasia serves as a leader in Deloitte & Touche LLP’s Capital Markets Transactions (CMT) group and leads the CMT Life Sciences industry offering, focusing on services related to transactions (IPOs, reverse mergers, SPACs), complex technical accounting, SEC reporting, financial statement reporting, and Sarbanes-Oxley implementation and compliance. She has more than 20 years of experience serving public and private companies in the life sciences, consumer products, aerospace and defense, and technology industries, and has spent the last 10 years focusing on emerging growth biotech and early-stage pharmaceutical companies.

Tasia is the San Diego market leader for the Accounting Advisory Services group, with a demonstrated track record of new business development and brand/market awareness. Prior to serving in this role, she focused on auditing emerging growth biotech and early-stage pharmaceutical companies in the San Diego market, and prior to that, worked in the private sector in various SEC reporting and technical accounting roles.

Ricae Feigleson is a host of exceptional ability. Studies show that a vast majority of guests attending events by Ricae have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

We encourage you to join using your laptop or phone video camera. An audio and/or visual warning will be provided upon entering the meeting and once recording commences. If you continue to participate in the meeting following this warning, your participation will serve as your express consent to such recording. Participant names may also be visible to all who join.

B.J. is an Audit & Assurance partner with Deloitte & Touche LLP, based in the Boston office, leading growth and delivery efforts in Deloitte’s Accounting & Reporting Advisory (ARA) practice across multiple industries and service offerings.
 

B.J. currently leads Deloitte’s Accounting & Reporting Advisory (ARA) practice in New England. In this role, B.J. is responsible for overseeing the execution and delivery of services that are targeted at helping CFOs and Controllers solve their complex and challenging projects. B.J. has extensive experience over 16+ years of working with a wide array of public and private companies of various sizes and across many industries. This includes serving as a trusted service provider to the individuals in the accounting and finance departments at these companies, and supporting them as they prepare to enhance their financial statements, business processes, controls, and overall organization as they adapt to challenges commonly faced when navigating US GAAP, SEC, and other professional requirements. Prior to serving in this role, B.J. was focused on serving audit clients of similar backgrounds and profiles and continues to assist the Audit & Assurance business.

John Haynor is a Managing Director at Solebury Capital where he is the Head of Structured Equity and also focuses on the healthcare sector across all products. Before joining Solebury in 2019, John worked in equity capital markets for 15 years most recently as a Managing Director at Jefferies. Prior to Jefferies, John worked on the Equity Capital Markets team at UBS. Over the course of his career, John has led the structuring and execution of IPOs, follow-on offerings, block trades, equity-linked offerings, SPAC capital raising and advisory, share repurchase strategies, 144A equity offerings and corporate derivative transactions. John has executed over 200 bookrun common stock and structured equity offerings for growth companies in the healthcare, life sciences, biotechnology and other sectors.

John is a graduate of Yale University and lives on Long Island, NY with his wife and three sons.

Carlos practices corporate and securities law, with an emphasis on private and public company representation and capital markets transactions. He represents companies throughout their life cycles, including in private and public financings, mergers and acquisitions, corporate governance matters, and Securities and Exchange Commission (SEC) reporting and compliance. He also advises venture capital funds and investment banking firms in connection with financings.

Carlos routinely represents issuers and investors in complex securities offerings – including initial public offerings (IPOs), follow-on offerings, 144A offerings and private placements.